Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07002749

ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
Patel Hospital, Pakistan · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH. THIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid (TXA)I would like to see the effect of prophylactic tranexamic acid in women undergoing ELLSCS in preventing PPH in my setup.
DEVICEPlaceboone group will get placebo

Timeline

Start date
2025-06-01
Primary completion
2025-06-01
Completion
2025-12-31
First posted
2025-06-04
Last updated
2025-06-04

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07002749. Inclusion in this directory is not an endorsement.